News

• LIFE is alive "Symmetry as a Fundamental Principle in Defining Gene Expression and Phenotypic Traits".
  "Symmetry refers to properties that remain invariant upon mathematical transformations, yet it remains unexplored in biology and medicine. We set to explore symmetry relationships in gene expression to distinguish between healthy and disease states. We deployed Learning-Based Invariant Feature Engineering - LIFE, a hybrid machine learning approach implemented with two symmetric invariant feature functions (IFFs) to identify Invariant Feature Genes (IFGs), which are gene pairs whose IFF single-value outputs remain invariant across individual samples in a given biological phenotype."
  January 2025
• ScienceDaily article "Nr1h2: A key transcription factor unlocks new potential in stem cell-based embryo models"
  "Nr1h2's identification as a master regulator of early embryogenesis opens new avenues for developmental biology. By refining stem cell-based embryo models, this discovery supports the design of targeted therapies, advances regenerative medicine, and improves our ability to explore the earliest stages of life."
  December 2024
• PHYS.ORG article "A key transcription factor unlocks new potential in stem cell-based embryo models"
  "Stem cell-based embryo models are revolutionizing drug discovery and reproductive biology. Nr1h2 activation rewires embryonic stem cells into an expanded pluripotent state, creating a robust platform to study early developmental processes and identify therapeutic targets."
  December 2024
• iethico article "Mayo Clinic Unveils Cutting-Edge AI for Precision Cancer Care"
  "Healthcare is on the cusp of a transformation, and at the heart of it lies a promising technology - artificial intelligence (AI). The Mayo Clinic, known for its pioneering medical research and patient care, has invented a healthcare AI that may revolutionize the way we diagnose and treat complex diseases, particularly cancer. This innovative AI, termed the Hypothesis-Driven AI (HDAI), is not just another algorithm looking at raw data sets; it's a carefully crafted tool designed to keep up with the dynamic knowledge of diseases like cancer in real-time. This is expected to usher in a new standard of precision medicine by marrying the power of AI with expert clinical insights. In conclusion, Mayo Clinic's Hypothesis-Driven AI stands as a testament to the power of marrying deep domain expertise with the agility of machine learning. Its potential to transform cancer care is not just promising, it's imminent. As we stand on the brink of this revolutionary change, it's clear that the implications are profound, and the future incredibly exciting - for patients, physicians, and medical researchers alike."
  September 2024
• Life Medicine Cover Story "Comparative dissection of transcriptional landscapes of human iPSC-NK differentiation and NK cell development."
  "Clinical and preclinical research has demonstrated that iPSC-derived NK (iNK) cells have a high therapeutic potential, yet poor understanding of the detailed process of their differentiation in vitro and their counterpart cell development in vivo has hindered therapeutic iNK cell production and engineering. Here we dissect the crucial differentiation of both fetal liver NK cells and iNK cells to enable the rational design of advanced iNK production protocols. We use a comparative analysis of single-cell RNA-seq (scRNA-seq) to pinpoint key factors lacking in the induced setting which we hypothesized would hinder iNK differentiation and/ or functionality."
  September 2024
• Targeted Oncology article "Elraglusib Granted FDA Orphan Drug Status in Soft Tissue Sarcoma"
  "The FDA has granted orphan drug designation (ODD) to elraglusib for the treatment of patients with soft tissue sarcoma (STS). Elraglusib is a novel GSK3B inhibitor. A phase 2 trial is currently evaluating elraglusib when given in combination with gemcitabine and docetaxel."
  September 2024
• futuro da SAUDE article by Isabella Marin "IA de hipoteses: nova classe de algoritmos pode ampliar potencial para descobertas sobre cancer e Alzheimer" (In Portuguese)
  "Pesquisadores da Mayo Clinic desenvolvem nova classe de algoritmos de inteligencia artificial com base em dominio de conhecimento e hipoteses."
  June 2024
• Omnia Health article "Researchers invent new class of AI algorithms to improve cancer research"
  "This opens a new avenue to understand cancer's interaction with the immune system, test medical hypotheses and predict response to immunotherapies."
  May 2024
• Lifespan.io article "Intermittent Fasting Induces Changes in Multiple Biomarkers"
  May 2024
• Inside Precision Medicine article "Mayo Clinic's Hypothesis-Driven AI Can Improve Treatment Strategies"
  "A new class of artificial intelligence (AI) called hypothesis-driven AI, invented recently by Mayo Clinic researchers, offers an innovative way to discover the complex causes of cancer and improve treatment strategies."
  April 2024
• ELBLOG.PL article "Innovative AI Algorithms Aimed at Hypothesis-Driven Cancer Research"
  "New AI algorithms have been developed by researchers that possess intuitive capabilities, enabling them not just to process data but to also work with hypotheses. This innovation marks a significant leap in cancer research and treatment advancement."
  April 2024
• tomorrow.bio article "Cancer's Kryptonite? Mayo Clinic's AI Improves Cancer Research and Aims for Personalized Treatments"
  The Science Behind Mayo Clinic's AI. "Uncover the groundbreaking advancements in cancer research as Mayo Clinic's AI technology revolutionizes the field, offering hope for personalized treatments."
  March 2024
• POLITICO article "When AI hurts patients, who pays?"
  "In addition to designing around a hypothesis, researchers use their expertise to incorporate their current understanding of how a disease works to curate training data, making it more efficient than traditional AI."
  March 2024
• The Voice Of World Control Article "Mayo Clinic Whizzes Cook Up 'Conjecture-Fueled AI' for Cancer Studies: A Witty Twist on Oncology!"
  "Mayo Clinic researchers have developed an artificial intelligence platform that can quickly sift through vast amounts of clinical data to generate new hypotheses, posing questions that can be tested in the lab or clinical trials.""
  "The beauty of the tech lies in its unrelenting tempo, unyielding accuracy, and most importantly, in its unwavering focus. Unlike human researchers who tend to be resistant to data contradicting their own hypotheses, this AI holds no prejudice. Its responses are free from cognitive biases, free from the shackles of pride or fear of failure. This beauty is all brain, no qualms."
  "For all its mighty and sc-fi-ike aspects, will this AI toss seasoned researchers on the ropes of irrelevance? Hardly. Indeed, it seems that the robo-researcher, with all its computational prowess, is here as an augment to human intellect rather than a replacement. It is a tool, a powerful, blazingly efficient tool, but a tool nonetheless."
  "So, dear humans, cheer up! This isn't a case of machines running amok with test tubes. It's just another grand advancement of tech in the service of humanity, arduously at work so that researchers can truly leap forward in their quest to unravel the mysteries that medical science holds. Buckle up, folks, for research and discovery just became a whole lot more exciting with AI on the team."
  March 2024
• THIS WEEK IN AI article "Mayo Clinic researchers are developing "hypothesis-driven AI" for oncology"
  Mayo Clinic researchers have developed an revolutionary AI technology called "hypothesis-driven AI," which deviates from traditional data-driven AI models.
  March 2024
• Mayo Clinic News Network article "Mayo researchers invented a new class of AI to improve cancer research and treatments"
  "Nonetheless, hypothesis-driven AI facilitates active interactions between human experts and AI, that relieve the worries that AI will eventually eliminate some professional jobs, says Dr. Li."
  March 2024
• GENE ONLINE article "Mayo Clinic Researchers Invent Hypothesis-Driven AI for Cancer Research Breakthroughs"
  "A team of Mayo Clinic researchers have recently unveiled a groundbreaking class of artificial intelligence (AI) algorithms known as hypothesis-driven AI. Unlike conventional AI models that rely solely on large datasets, these new algorithms incorporate existing scientific knowledge and hypotheses."
  March 2024
• IndiaNext article "A New Kind Of AI Was Created By Mayo Researchers To Advance Cancer Research And Therapy"
  "As hypothesis-driven AI is still in its infancy, there are still issues to be resolved, like how to combine biological data and knowledge in the most effective way to reduce bias and enhance interpretation. Dr. Li asserts that hypothesis-driven AI is a positive development despite its difficulties."
  March 2024
• Cryptopolitan article "Researchers Find Nwe AI Algorithms to Combat Cancer"
  "The potential applications of hypothesis-driven AI in cancer research are vast. From classifying tumors to predicting how a patient might respond to a certain therapy, this AI could transform the field. It's not just about having more data but using it smarter, with a clear focus on open scientific questions."
  March 2024
• ARC article "REVOLUTIONIZING DISEASE DIAGNOSIS: MAYO CLINIC'S BREAKTHROUGH AI ALGORITHM"
  "In an unprecedented advancement in medical technology, the Mayo Clinic has introduced a groundbreaking artificial intelligence (AI) algorithm poised to transform the landscape of disease diagnosis. This innovative approach, known as hypothesis-driven AI, represents a significant departure from conventional AI models. By leveraging a novel method for processing extensive datasets, this AI algorithm is capable of uncovering the intricate causes behind various diseases, including cancer. This development signifies a monumental stride in medical research and patient care, highlighting the immense potential of AI in revolutionizing healthcare."
  March 2024
• TechTarget news on "Mayo Clinic develops novel AI class to advance cancer research, care"
  "Hypothesis-driven artificial intelligence could enhance cancer studies and guide personalized treatment by focusing on specific research questions."
  "The research team underscored that this new type of AI is designed to incorporate specific hypotheses or research questions, rather than simply relying on data alone, as in traditional models. They posited that the approach could help enhance knowledge discovery efforts in medicine."
  March 2024
• Youtube Artificial Intelligence Podcast "Revolutionizing Medicine: Mayo Clinic Introduces Hypothesis-Driven AI"
  March 2024
• HEALTH IT ANALYTICS article "Mayo Clinic develops novel AI class to advance cancer research, care"
  "Hypothesis-driven artificial intelligence could enhance cancer studies and guide personalized treatment by focusing on specific research questions."
  March 2024
• MIT Sloan Management Review article "Mayo Clinic's Healthy Model for AI Success"
  March 2024
• Becker's Health IT article "Mayo Clinic invents new healthcare AI"
  March 2024
• Technology Networks article "New Class of Artificial Intelligence Can Advance Cancer Research"
  March 2024
• MSN article "Researchers Find New AI Algorithms to Combat Cancer"
  March 2024
• DAILY.AI article "Mayo Clinic researchers develop "hypothesis-driven AI" for oncology"
  March 2024
• NEWS MEDICAL SCIENCES article "New class of AI tackles complex diseases by incorporating scientific knowledge"
  March 2024
• Hypothesis-Driven Artificial Intelligence: a newly invented class of AI
  Feburary 2024
• Mayo Clinic Discovery's Edge article on "Mapping cell behaviors in high-grade glioma to improve treatment"
  Feburary 2024
• The CLEAR-AD first Annual External Advisory Board (EAB) Meeting has been successfully hold at Mayo Clinic Florida, Cannaday Building, Kinne Auditorium.
  January 2024
• SPIN-AI was selected as one of the 10 significant studies from Mayo Clinic's Center for Individualized Medicine in 2023
  December 2023
• The novel Multi-Scale models: Locked-State Model (LoSM). Drug Discovery Today Feature Article on "Multiorgan locked-state model of chronic diseases and systems pharmacology opportunities"
  November 2023
• Groundbreaking technology sheds light on the mysteries of RNA modifications.
  "This new technology, known as "single-nucleus m6A-CUT&Tag" (sn-m6A-CT), profiles m6A modifications in unmodified single cells, and is compatible with simultaneous profiling m6A methylomes and transcriptomes in the same cell. Currently, there is no method available for m6A profiling in native populations of cells at the single-cell level, Our technology successfully addressed the challenge of signal dilution caused by bulk sampling in a diverse cell population. "This is the first m6A high-resolution assay in native populations of cells and it has the potential to revolutionise our understanding of RNA heterogeneity and abnormalities," highlighted Prof. Jonathan Loh, Deputy Executive Director of IMCB. Importantly, the new technology can provide deeper insights into precision medicine. "These findings provide our researchers and clinicians an immensely valuable platform for investigating molecular signatures from a diagnostic perspective," said Prof. Hu Li from Mayo Clinic, an international collaborator on this study."
  November 2023
• linkedin post on sn-m6A-CT "Decorating our homes is an important part of setting the mood of our daily lives."
  October 2023
• CN-Healthcare: Relationship between BCL2 mutations and follicular lymphoma outcome in the chemoimmunotherapy era.
  October 2023
• Medical Express: Study finds senescent immune cells promote lung tumor growth.
  September 2023
• eCancer: Study finds senescent immune cells promote lung tumor growth.
  September 2023
• Science Saturday: Study finds senescent immune cells promote lung tumor growth.
  July 2023
• LinkedIn "Mayo Clinic researchers pioneer AI method to predict how cells are organized in disease microenvironments".
  June 2023
• Mayo Clinic News Network Article on "Mayo Clinic researchers pioneer AI method to predict how cells are organized in disease microenvironments".
  "Knowing how cells are organized and communicate in diseases is paramount for a better understanding of what caused the disease, and for the formulation of new therapeutic designs. Using their SPIN-AI innovation, the researchers discovered a new class of genes, which they have named "spatially predictive genes." These genes provide clues about where they are active or "turned on" within a cellular niche. By studying these genes, the researchers say they can gain insights into how cells are meticulously organized, and the role they are playing in the functioning of specific areas."
  June 2023
• PHYS.ORG Article on "AI method predicts how cells are organized in disease microenvironments".
  June 2023
• Discovery's Edge Article on "Study finds senescent immune cells promote lung tumor growth".
  June 2023
• Cancer Cell Preview: Senescent macrophages: A new "old" player in lung cancer development.
  June 2023
• Former trainee Victoria Rosa was Named 2023 Goldwater Scholars
  May 2023
• Frontiers in Immunology Editorial: Decoding immunologic complex systems in cancer: the cutting-edge technologies revolutionizing cancer immunology and immunotherapy
  May 2023
• V Foundation and Jeff Gordon Children's Foundation All Star Grant Awrad Call.
  Dr. Zhu joined a Zoom call thinking she would be asked about her research proposal. Instead, Dr. Zhu was surprised by members of the V Foundation and Jeff Gordon Children's Foundation as they announced that she was awarded a Pediatric All-Star Grant co-funded by the organizations.
  April 2023
• Centrally-linked longitudinal peripheral biomarkers of AD in multi-ethnic populations: CLEAR-AD (U19 AG074879)
  March 2023
• $41 million federal grant to help Mayo Clinic, collaborators advance multiethnic Alzheimer's research
  March 2023
• Individualized Medicine Blog article on "New AI algorithm opens avenues for knowledge discoveries"
  "In a proof-of-concept study, Hu Li, Ph.D., a Mayo Clinic Center for Individualized Medicine systems biologist, developed a new artificial intelligence (AI) algorithm which uses novel weight engineering methods to extract meaningful biological knowledge learned by AI models."
  Auguest 2022
• Digital Journal article on "New senolytic targets were identified"
  July 2022
• Fighting Aging! article on "In Search of More Ways to Destroy Senescent Cells by Unleashing p53"
  July 2022
• Mayo Clinic NewsNetwrok article on "Science Saturday: Mayo researchers lay foundation for AI-based personalized cancer modeling"
  "The astounding genetic and phenotypic variation in cancer is well-known; yet, almost all research and clinical practice focuses on cohorts of patients where risk factors are averaged together. To have successful and reliable artificial intelligence algorithms, you need high-value inputs that encode meaningful biological information about patient disease. PERMUTOR can provide such inputs to feed artificial intelligence platform."
  Feburary 2022
• Inside Mayo Clinic Research article on "AI tool paves way for personalized cancer modeling"
  February 2022
• Discovery's Edge article on "Mayo Researchers Lay Foundation for AI-Based Personalized Cancer Modeling"
  January 2022
• genomeweb news "Genome Research Paper Present Pipeline for Individualized Disease Modules"
  December 2021
• AZO Life Sciences article on "Experts create world's first single-cell atlas of human and porcine eyes"
  December 2021
• ScienceDaily article on "First single-cell atlas of human, porcine eyes maps genes involved in eye disorders"
  "Scientists have constructed a single-cell atlas of the human and porcine eyes. This has allowed them to create a disease map of genes involved in eye disorders across the different cell types, as well as the key switches which control cell specialization of individual ocular tissues. The work would help to provide new insights about human eye diseases and age-related eye disorders, and potentially pave the way for regenerative medicine and cell replacement therapies for eye diseases."
  December 2021
• Ophthalmology Times article on "Scientists construct first single-cell atlas of human, porcine eyes maps genes involved in eye disorders"
  December 2021
• Technology Networks article on "First Single-Cell Atlas of the Human Eye Constructed"
  December 2021
• RNASEQ BLOG article on "First single-cell atlas of the human eye constructed"
  December 2021
• New studies link cell cycle proteins to immunosurveillance of premalignant cells
  December 2021
• Science Perspectives article on "Clearing stressed cells"
  October 2021
• Drug Discovery Today Feature Article on "Manifold Medicine: A Schema that Expands Treatment Dimensionality"
  October 2021
• Medical Xpress articel on "Metabolic remodeling during early mouse embryo development"
  October 2021
• ALZFORUM article on "Methylated RNA: A New Player in Tau Toxicity?"
  September 2021
• Medical Xpress article on "First study to investigate the role of RNA tags in Alzheimer's disease"
  August 2021
• Nature Aging News & Views article on "SNCs meet SMCs in the atherosclerotic plaque"
  August 2021
• Mayo researchers, collaborators identify 'instigator' gene associated with Alzheimer's disease
  April 2021
• Meet My Research: Taylor Weiskittel
  April 2021
• EDDI - (Expression Dosage Dependent Inferelator) is a machine learning and systems biology approach to characterize dosage-based gene dependencies is online available
  March 2021
• SG55: 55 Scientists, One Voice, One Target, Fight COVID-19, "We Will Get There"
  June 2020
• News-Medical article "Potential for COVID-19 transmission from human eye"
  May 2020
• ScienceDaily News "Diet impacts the sensitivity of gut microbiome to antibiotics, mouse study finds"
  September 2019
• News-Medical article "What you eat may change the way that antibiotics affect your gut"
  September 2019
• National academy of engineers alumni spotlight on Taylor Weiskittel, MD PhD Student at Mayo Clinic Alix School of Medicine Medical Scientist Training Program
  July 2019
• RSI - Regulostat Inferelator: a novel network biology platform to uncover molecular devices that predetermine cellular response phenotypes is online available
  May 2019
• The ALS Research Forum article on "Mitofusin2: CASTing A Line To Protect Muscles in ALS"
  November 2018
• BioSpace article on "A*STAR Institute and Mayo Clinic Identify Key Protein to Convert Skin Cells into Other Types of Cells"
  July 2018
• BioSpectrum article on "Ground-breaking study to hasten regenerative medicine development"
  July 2018
• CIFAR-GETx Conference: Brave New World. Utilizing Genetic Networks to Decode Complex Disease.
  June 2018
• MedGadget article on "Intestine on a Chip Technique Opens Door to Personalized Medicine"
  February 2018
• PHYS.ORG article on "True to type: From human biopsy to complex gut physiology on a chip"
  February 2018
• Neuroscience News Featured "Researchers Describe a New Biology of Alzheimer's disease"
  November 2017
• UAB News "Finding a key to unlock blocked differentiation in microRNA-deficient embryonic stem cells"
  November 2017
• ALZFORUM article on "Stress Granule Protein Stabilizes Tau Oligomers, Hastens Neurodegeneration"
  November 2017
• RELIAWIRE article on "Decreasing RNA Stress Granules May Slow Alzheimer's"
  November 2017
• Mayo Clinic researchers identify genes fueling neuroblastoma spread
  September 2017
• Cancer Cell Previews article on "When LMO1 Meets MYCN, Neuroblastoma Is Metastatic"
  September 2017
• Nature Cell Biology News & Views on "A fruitful liaison of ZSCAN10 and ROS on the road to rejuvenation"
  August 2017
• MALANI - Machine Learning-Assisted Network Inference approach to identify cryptic genes that coordinate the functionality of cancer networks is online available
  August 2017
• The Prestigious W.M. Keck Foundation Funds 2017 Medical Research Grants
  August 2017
• Alzheimer's & Dementia article on "TAU-INDUCED NEURODEGENERATION IS MEDIATED BY RNA BINDING PROTEINS"
  July 2017
• Mayo Clinic researchers use zebrafish to identify potential treatment for pediatric cancer
  April 2017
• P-Map - a network-based phenotype mapping approach to identify genes that modulate drug response phenotypes is online available
  November 2016
• ACN Newswire article on "Scientists Successfully Create Blood from Skin Cells. Development could pave way for improved therapeutics for patients with immune disorders"
  November 2016
• ALZFORUM article on "Unleashed From the Nucleus, TDP-43 Wreaks Havoc in Mitochondria"
  July 2016
• Cell Stem Cell Previews article on "Metabolic RemodeLIN of Pluripotency"
  July 2016
• Discovery Science news on "Mayo Researcher Contributes to Immune System Collaboration"
  July 2016
• NetDecoder - a network-based platform to decode context-specific biological networks and gene activities is online available
  June 2016
• DISCOVERY's EDGE news on "Mayo Researcher Contributes to Immune System Collaboration"
  June 2016
• Li's team at Mayo Clinic is part of a multi-institutional, DARPA-funded initiative called Technologies for Host Resilience (THoR) to uncover underlying causes of tolerance to infection.
  May 2016
• Harvard Wyss Institute to lead multi-institutional project to uncover underlying causes of tolerance to infection.
  May 2016
• DailyMail news on "Could STRESS trigger Alzheimer's? Chronic stress 'causes key proteins to cluster in the brain, triggering the disease'"
  May 2016
• Science Daily news on "Researchers identify new pathway leading to Alzheimer's disease"
  May 2016
• Nature Genetics blog on "Bacterial methylomes and antibiotic potentiation"
  March 2016
• American Chemical Society spotlight on "Microdevice enables long-term coculturing of microbes and cells, providing an in vitro model of human intestinal disease"
  February 2016
• IBD News Today article on "Gut-on-a-Chip Technology Provides Breakthrough in Microbiome Reseach"
  December 2015
• Newswise article on "A cultural revolution in the study of the gut microbiome"
  December 2015
• R&D article on "Gut-on-a-chip holds clues for treating inflammatory bowel diseases"
  December 2015
• Cell Preview article on "Revealing the complexity of retroviral repression"
  September 2015
• Science Daily news on "Scientists reveal how stem cells defend against viruses"
  September 2015
• Nature Reviews Neurology article on "Motor neuron disease: Brain transcriptome profiling reveals involvement of divergent pathways in C9orf72-associated and sporadic ALS."
  September 2015
• Nature Neuroscience article on "The RNAs of ALS".
  August 2015
• Technology Network article on "Study uncovers key differences among ALS patients."
  July 2015
• Mayo Clinic News Network article on "Mayo Clinic study uncovers key differences among ALS patients"
  July 2015
• ScienceDaily article on "Study uncovers key differences among ALS patients"
  July 2015
• ALS Association News on "Insights into Gene Changes in Different Forms of ALS"
  July 2015
• ALS News Today article on "Differences Among ALS Patients Might Be The Key to Novel Therapies"
  July 2015
• ALZFORUM article on "C9ORF72, Sporadic ALS Transcriptomes Now Available"
  July 2015
• MIT News article on "Repurposed anti-cholesterol drug could improve treatment-resistant anemias"
  May 2015
• Nature article on "Time management: Seize the moment" about time management as a new Principle Investigator.
  January 2015
• Nature Biotechnology News and Views on "A blueprint of cell identity"
  October 2014
• Nature Methods article on "A systems view of cellular reprogramming"
  September 2014
• Nature News & Views on "A compass for stem-cell differentiation"
  September 2014
• Harvard Medical School News & Research article on "Performance Reviews for Stem Cells - New algorithm provides roadmap and quality assurance for lab-created stem cells"
  August 2014
• Cell Preview article on "CellNet--where your cells are standing"
  August 2014
• Science Daily article on "New tool aids stem cell engineering for medical research"
  August 2014
• Mayo Clinic News Network article on "New Tool Aids Stem Cell Engineering for Medical Research"
  August 2014
• Post-Bulletin article on "Regenerative medicine research tool allows researchers public access"
  August 2014
• Stem Cell Doctors article on "New Tool Aids Stem Cell Engineering for Medical Research"
  August 2014
• Imperial Valley News article on "New tool aids stem cell engineering for medical research"
  August 2014
• Boston Business Journal article on "Boston scientists develop analytics for stem cell engineering"
  August 2014
• Health IT Analytics article on "Stem cell 'roadmap' brings analytics to tissue engineering"
  August 2014
• Science & Enterprise article on "System tests quality of engineered stem cells, tissue"
  August 2014
• Vector article on "Stem cell medicine gets a 'roadmap'"
  August 2014
• Boston Magazine article on "Boston researchers develop stem cell roadmap"
  August 2014
• News Medical article on "Scientists create computer algorithm for cell and tissue engineering"
  August 2014
• Genetic Engineering and Biotechnology News highlight on "Mapping cell fate conversion via CellNet"
  August 2014
• Cell Preview article on "CellNet - where your cells are standing"
  August 2014
• Harvard Medical School News article on "Performance reviews for stem cells"
  August 2014
• Breast Cancer Research article on "Combining the strength of genomics, nanoparticle technology, and direct intraductal delivery for breast cancer treatment"
  May 2014
• Science Daily article on "Novel non-invasive therapy prevents breast cancer formation in mice"
  January 2014
• Bionews article on "Gene-blocking injection halts breast cancer progression in mice"
  January 2014
• Medical Daily article on "New Noninvasive Procedure Targeting Single Gene May Halt Breast Cancer Development"
  January 2014
• NHS Choices article on "Early animal research into blocking breast cancer"
  January 2014
• Nature Methods article on "Stem cells: Blood matters"
  December 2012
• F1000Prime Recommended Article
  January 2011
• Nature Methods article on "RNA-based reprogramming"
  January 2011
• Cellular reprogramming and Synthetic Biology were highlighted in Science's "Breakthrough of the Year" issue
  December 2010
• Top 7 papers in cell biology
  December 2010
• Cell Stem Cell Preview article on "Synthetic mRNAs"
  November 2010
• Science News of the Week article on "New technique riPS open stem cell field"
  October 2010
• Nature Biotechnology Research Highlights on "iPS cells from blood"
  August 2010
• Cell Stem Cell Preview article on "Patient-specific pluripotent stem cells become even more accessible"
  July 2010